Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate vs propofol for sedation in hysteroscopic day surgery
ChiCTR2100048738Phase 4Not yet recruiting
- Sponsor
- Shunde Women and Children's Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in Procedural anxiety and Perioperative anxiety (2 arms), sponsored by Shunde Women and Children's Hospital. Primary endpoints: Sedation success rate, Incidence of hypotension and 2 more. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Procedural anxietyPerioperative anxiety
Beyond the preview
Go deeper on ChiCTR2100048738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048738.